API Delivery Gel
Total Trials
2
As Lead Sponsor
As Collaborator
0
Total Enrollment
424
NCT04632706
Exploratory Ph I Trial of the Active IMP in Healthy Volunteers in Relation to COVID-19
Phase: Phase 1
Role: Lead Sponsor
Start: Sep 22, 2020
Completion: Mar 9, 2021
NCT05305560
A Study to Evaluate the Efficacy and Safety of Ivermectin in COVID-19 Prevention
Phase: Phase 2
Start: Mar 25, 2022
Completion: Oct 13, 2022
Loading map...